Increasingly people are hearing about copyright and other GLP-1 therapies due to their observed impact in body composition changes. Originally designed to treat type 2 diabetes , these GLP-1 receptor agonists work by imitating a natural hormone that regulates appetite and slows gastric motility . This dual action can result in significant body fat